{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T19:52:37Z","timestamp":1766087557155,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.colsurfb.2020.111119","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:09:56Z","timestamp":1589155796000},"page":"111119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Improvement of the pharmacokinetic\/pharmacodynamic relationship in the treatment of invasive aspergillosis with voriconazole. Reduced drug toxicity through novel rapid release formulations"],"prefix":"10.1016","volume":"193","author":[{"given":"Teresa","family":"Gallego-Arranz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9238-5849","authenticated-orcid":false,"given":"Alba","family":"P\u00e9rez-Cantero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Torrado-Salmer\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edctor","family":"Guarnizo-Herrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Capilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3273-2615","authenticated-orcid":false,"given":"Santiago","family":"Torrado-Dur\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2020.111119_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jof4030098","article-title":"Treatment of aspergillosis","volume":"4","author":"Jenks","year":"2018","journal-title":"J. Fungi."},{"key":"10.1016\/j.colsurfb.2020.111119_bib0010","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.colsurfb.2020.111119_bib0015","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s12325-016-0443-1","article-title":"Cost-effectiveness analysis of isavuconazole vs. voriconazole as first-line treatment for invasive Aspergillosis","volume":"34","author":"Harrington","year":"2017","journal-title":"Adv. Ther."},{"key":"10.1016\/j.colsurfb.2020.111119_bib0020","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.colsurfa.2018.08.082","article-title":"Improved delivery of voriconazole to Aspergillus fumigatus through solid lipid nanoparticles as an effective carrier","volume":"558","author":"Kelidari","year":"2018","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.colsurfb.2020.111119_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2006.01.003","article-title":"Clinical pharmacokinetics of voriconazole","author":"Lev\u00eaque","year":"2006","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.colsurfb.2020.111119_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms17030282","article-title":"Two different approaches for oral administration of voriconazole loaded formulations: electrospun fibers versus \u03b2-cyclodextrin complexes","volume":"17","author":"Siafaka","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2020.111119_bib0035","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ijpharm.2017.10.051","article-title":"Amorphous solid dispersions and nanocrystal technologies for poorly water-soluble drug delivery \u2013 an update","volume":"535","author":"Jermain","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2020.111119_bib0040","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jddst.2017.06.010","article-title":"Application of surfactants in solid dispersion technology for improving solubility of poorly water soluble drugs","volume":"41","author":"Chaudhari","year":"2017","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.colsurfb.2020.111119_bib0045","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ijpharm.2017.07.028","article-title":"Improvement of the surface hydrophilic properties of naproxen particles with addition of hydroxypropylmethyl cellulose and sodium dodecyl sulphate: in vitro and in vivo studies","volume":"529","author":"Garc\u00eda-Herrero","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2020.111119_bib0050","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.colsurfb.2019.06.050","article-title":"Ginkgolides-loaded soybean phospholipid-stabilized nanosuspension with improved storage stability and in vivo bioavailability","volume":"181","author":"Wang","year":"2019","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.colsurfb.2020.111119_bib0055","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijantimicag.2014.05.019","article-title":"Voriconazole pharmacokinetics and exposure-response relationships: assessing the links between exposure, efficacy and toxicity","volume":"44","author":"Dolton","year":"2014","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.colsurfb.2020.111119_bib0060","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejpb.2016.12.019","article-title":"Polymeric mixed micelles as nanomedicines: achievements and perspectives","volume":"113","author":"Cagel","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2020.111119_bib0065","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.colsurfb.2016.10.028","article-title":"Self dispersing mixed micelles forming systems for enhanced dissolution and intestinal permeability of hydrochlorothiazide","volume":"149","author":"Sultan","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.colsurfb.2020.111119_bib0070","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/toxsci\/kfx029","article-title":"Hepatocellular toxicity of imidazole and triazole antimycotic agents","volume":"157","author":"Haegler","year":"2017","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.colsurfb.2020.111119_bib0075","first-page":"6395","article-title":"Preparation, characterization, in vivo pharmacokinetics, and biodistribution of polymeric micellar dimethoxycurcumin for tumor targeting","volume":"10","author":"Liu","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2020.111119_bib0080","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ejpb.2014.10.010","article-title":"Pulmonary delivered polymeric micelles - pharmacokinetic evaluation and biodistribution studies","volume":"88","author":"Hu","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2020.111119_bib0085","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.carbpol.2013.05.084","article-title":"Spray-dried voriconazole-cyclodextrin complexes: solubility, dissolution rate and chemical stability","volume":"98","author":"Miletic","year":"2013","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.colsurfb.2020.111119_bib0090","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1128\/JCM.00536-10","article-title":"Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document)","volume":"48","author":"Espinel-Ingroff","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.colsurfb.2020.111119_bib0095","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1128\/JCM.40.6.2101-2107.2002","article-title":"E-test method for testing susceptibilities of society","volume":"40","author":"Espinel-ingroff","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.colsurfb.2020.111119_bib0100","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijantimicag.2008.08.020","article-title":"Free renal levels of voriconazole determined by microdialysis in healthy and Candida sp.-infected Wistar rats","volume":"33","author":"de Araujo","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.colsurfb.2020.111119_bib0105","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1086\/377131","article-title":"Voriconazole concentrations in the cerebrospinal fluid and brain tissue of Guinea pigs and immunocompromised patients","volume":"37","author":"Lutsar","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.colsurfb.2020.111119_bib0110","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1128\/AAC.00957-06","article-title":"Variability of voriconazole plasma levels measured by new high-performance liquid chromatography and bioassay methods","volume":"51","author":"Pascual","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.colsurfb.2020.111119_bib0115","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1080\/03639045.2016.1185436","article-title":"Modulation of the wettability of excipients by surfactant and its impacts on the disintegration and release of tablets","volume":"42","author":"Yang","year":"2016","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.colsurfb.2020.111119_bib0120","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijpharm.2012.03.010","article-title":"Effect of process variables on morphology and aerodynamic properties of voriconazole formulations produced by thin film freezing","volume":"429","author":"Beinborn","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2020.111119_bib0125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ejpb.2017.06.024","article-title":"Effect of amphiphilic graft co-polymer-carrier on physical stability of bosentan nanocomposite: assessment of solubility, dissolution and bioavailability","volume":"126","author":"Kendre","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2020.111119_bib0130","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jpba.2018.05.023","article-title":"Applications of various analytical techniques in quality control of pharmaceutical excipients","volume":"157","author":"Kumar","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.colsurfb.2020.111119_bib0135","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejps.2014.09.004","article-title":"Interactions between active pharmaceutical ingredients and excipients affecting bioavailability: impact on bioequivalence","volume":"65","author":"Garc\u00eda-Arieta","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2020.111119_bib0140","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.colsurfa.2017.11.017","article-title":"Hydrophobic agglomeration of talc fines in aqueous suspensions","volume":"538","author":"Yi","year":"2018","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.colsurfb.2020.111119_bib0145","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1128\/AAC.06015-11","article-title":"Experimental central nervous system aspergillosis therapy: efficacy, drug levels and localization, immunohistopathology, and toxicity","volume":"56","author":"Clemons","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.colsurfb.2020.111119_bib0150","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1128\/AAC.47.12.3976-3978.2003","article-title":"Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic mice","volume":"47","author":"Capilla","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.colsurfb.2020.111119_bib0155","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.diagmicrobio.2015.09.010","article-title":"Voriconazole and posaconazole therapy for experimental Candida lusitaniae infection","volume":"84","author":"Sanchis","year":"2016","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.colsurfb.2020.111119_bib0160","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/cpt.943","article-title":"Effect of sorbitol on the pharmacokinetic profile of lamivudine oral solution in adults: an open-label, randomized study","volume":"103","author":"Adkison","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.colsurfb.2020.111119_bib0165","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1080\/10717544.2018.1492046","article-title":"Intravenous delivery of a liposomal formulation of voriconazole improves drug pharmacokinetics, tissue distribution, and enhances antifungal activity","volume":"25","author":"Veloso","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.colsurfb.2020.111119_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.00489-18","article-title":"Efficacy, biodistribution, and nephrotoxicity of experimental amphotericin B-deoxycholate formulations for pulmonary aspergillosis","volume":"62","author":"L\u00f3pez-S\u00e1nchez","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.colsurfb.2020.111119_bib0175","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/FTD.0b013e318167d0e0","article-title":"Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations","volume":"30","author":"Smith","year":"2008","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.colsurfb.2020.111119_bib0180","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1021\/acs.biomac.7b00995","article-title":"Influence of size and shape on the biodistribution of nanoparticles prepared by polymerization-induced self-assembly","volume":"18","author":"Kaga","year":"2017","journal-title":"Biomacromolecules."},{"key":"10.1016\/j.colsurfb.2020.111119_bib0185","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.colsurfb.2019.01.044","article-title":"Tumor-targeting micelles based on folic acid and \u03b1-tocopherol succinate conjugated hyaluronic acid for paclitaxel delivery","volume":"177","author":"Zhang","year":"2019","journal-title":"Colloids Surf. B Biointerfaces"}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776520303490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776520303490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:56:01Z","timestamp":1760525761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776520303490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":37,"alternative-id":["S0927776520303490"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2020.111119","relation":{},"ISSN":["0927-7765"],"issn-type":[{"type":"print","value":"0927-7765"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improvement of the pharmacokinetic\/pharmacodynamic relationship in the treatment of invasive aspergillosis with voriconazole. Reduced drug toxicity through novel rapid release formulations","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2020.111119","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111119"}}